Term
|
Definition
host organism's response to a pathogen, or a disease-causing substance occures when tissue-destroying microorganisms enter & multiply in the body to cause disease, microbial pathogens must adhere to cell surface, colonize & invade the host and proliferate inside |
|
|
Term
some infections take the form of minor illnesses, others result in a life-threatening condition called ____, causing widespread vasodilation and multiorgan system failure (shock) |
|
Definition
|
|
Term
|
Definition
severe condition in which infection has spread into the blood |
|
|
Term
infection-causing microbes (2) |
|
Definition
|
|
Term
|
Definition
microscopic genetic parasites that contain genetic material (DNA or RNA) but have no metabolic capability & need a host cell to replicate (no cell walls, membranes, etc) |
|
|
Term
|
Definition
single-celled microorganisms that have no true nucleus & reproduce by cell division pathogenic bacteria contain cell-damaging proteins that cause infection; these proteins come in two forms: exotoxins endotoxins |
|
|
Term
cell damaging proteins contained in pathogenic bacteria: exotoxins |
|
Definition
released during cell growth |
|
|
Term
cell-damaging proteins in pathogenic bacteria that cause infection: endotoxins |
|
Definition
released when the bacterial cell wall decomposes; they cause fever & are not affected by antibiotics (can be dangerous to the host) |
|
|
Term
bacteria are classifed by several different ways: |
|
Definition
by shape, growth requirements, motility & whether they are aerobic (requiring oxygen) or anaerobic |
|
|
Term
gram-positive bacteria 2 examples? |
|
Definition
these are everywhere; everything going on in the community streptococcal organisms staphylococcal organisms (gram-positive rods are not commonly seen) |
|
|
Term
|
Definition
encountered at the hospital include gram-negative rods and cocci & gram-negative obligate intracellular parasites |
|
|
Term
|
Definition
no cell wall include mycoplasma and chlamydia |
|
|
Term
|
Definition
nonphotosynthetic microorganisms that reproduce asexually (by division) & contain a true nucleus |
|
|
Term
2 classifications of fungi |
|
Definition
yeast: round, single celled facultative anaerobes that can live with or without oxygen molds: filament-like, mutinucleated, aerobic microorganisms mycotic infections: infections caused by fungi; pathogenic fungi release mycotoxins
|
|
|
Term
|
Definition
single-celled or multicelled organisms that depend on a host for food & a protective environment most common parasitic infections, such as tapeworm infestation, occur in the intestines |
|
|
Term
|
Definition
agents (natural, synthetic, semi-synthetic) which kill or inhibit growth of microorganisms (pathogens) |
|
|
Term
|
Definition
substances produced by certain organisms which kill or inhibit the growth of other microorganisms subset of antimicrobials sulfa drugs: only ones that come from the lab |
|
|
Term
|
Definition
ability to kill an invading microorganism w/o harming the cells of the host possibly b/c microbial pathogens difer in cellular structures or biochemical processes from human hosts this is the most important quality aside from effectiveness |
|
|
Term
classification of antimicrobial agents |
|
Definition
bactericidal-bacteriostatic actions site of action/mechanisms of action |
|
|
Term
|
Definition
arrest the growth & replication of bacteria, thus giving the body's immune system a chance to destroy & remove the pathogens depend on the host having an intact immune status (so immune system can finish the job) cannot be used in life-threatening situations; too slow to act e.g. erythromycin, tetracyclines, sulfonamides |
|
|
Term
|
Definition
drugs that kill microorganisms less dependent on the host's defense mechanisms for their therapeutic effects (so, drug of choice for HIV pts, etc) e.g. beta-lactam antibiotics, penicillins, vancomycin |
|
|
Term
bactericidal agents are preferred in tx of _____ |
|
Definition
serious, life-threatening infections and/or when the host's immune system is not functioning properly |
|
|
Term
some antimicrobial drugs may exert either a bactericidal or a bacteriostatic action depending on ____ |
|
Definition
the dose used causative organism being acted upon site of action of the drug |
|
|
Term
site of action/mechanisms of action 4 categories |
|
Definition
inhibitors of bacterial cell wall synthesis inhibitors of bacterial protein synthesis inhibitors of bacterial metabolism (nucleic acid synthesis, energy metabolism) disruptors of cell membrane permeability |
|
|
Term
inhibitors of bacterial cell wall synthesis |
|
Definition
bactericidal effective on "growing" bacteria that synthesize a peptidoglycan cell wall; should not be combined w/ bacteriostatic drugs also inactive against organisms devoid of this structure (fungi, viruses, etc) selectively interfere w/ the synthesis of the bacterial cell wall bacterial cell walls are thicker & more rigid than the membranes of mammalian cells; they contain complex macromolecules that are formed via biosynthetic pathways which are absent from mammalian cells block the cross-linking of peptidoglycan chains, which is the final step in bacterial cell wall synthesis, thereby producing deficiencies in the cell walls; interior of the cell is hypertonic, H20 enters the interior of the cell & causes lysis |
|
|
Term
inhibitors of bacterial cell wall synthesis examples: |
|
Definition
penicillins, cephalosporins, monobactams, carbapenems, bacitracin (topical), vancomycin |
|
|
Term
disruptors of cell membrane permeability |
|
Definition
increase the permeability of the bacterial cell membrane thereby permitting leakage of intracellular components to take place differing ratios btwn sterol & phospholipid contents in mammalian & microbial cell membrane appear to be the basis for the selectivity of these agents considered bactericidal in their action since interference w/ the cell membrane results in the immediate death of microbes |
|
|
Term
disruptors of cell membrane permeability examples: |
|
Definition
amphothericin B, imidazoles, polymixins |
|
|
Term
inhibitors of bacterial protein synthesis |
|
Definition
affect bacterial protein synthesis w/ relative selectivity target the bacterial ribosome (smaller than the mammalian ribosome) mammalian mitochondrial ribosome more closely resembles the bacterial chromosome; although drugs usually spare the host cells, high levels of drugs may cause toxic effects as a result of interaction w/ the mitochondrial ribosomes (relative selectivity) |
|
|
Term
inhibitors of bacterial protein synthesis examples: |
|
Definition
aminoglycosides (cidal), tetracyclines, macrolytes, clindamycin, chloramphenicol, streptogamin |
|
|
Term
inhibitors of bacterial metabolism |
|
Definition
nucleic acid synthesis inhibitors of nucleic acid synthesis; bactericidal (quinolones, fluoroquinolones) foliate antagonists inhibit folic acid synth; in the absence of folic acid, cells cannot grow or divide (folic acid coenzynes are required for the synth of purines & pyrimidines - precursors of RNA/DNA) humans obtain folate in the diet, but many microorganisms must synthesize this substance by using PABA as substrate function as competitive analogues of PABA bacteriostatic alone & bactericidal in combo (sulfonamides, trimethaprim, bactrim) |
|
|
Term
|
Definition
refers to the ability of a microorganism to withstand a drug that was previously toxic to it many orgainisms have adopted, through spontaneous mutation or acquired resistance & selection & developed more virulent stains many of which are more resistant to multiple abx cross resistance can occur btwn antimicrobial drugs, especially if they are chemically related & have similar mechanisms of action |
|
|
Term
four basic mechanisms by which microorganisms can become resistant to abx |
|
Definition
production of drug-inactivation enzymes e.g. B-lactamases destroy many penicillins/cephalosporins changes in drug penetration microbes may adopt to become impermeable to the abx or increase their ability to excrete the abx; aminoglycosides, tetracyclines changes in receptor structure abx such as erythromycin bind to certain receptors; microorganisms can cause these receptors to mutate so that they have very little affinity for abx alterations of metabolic pathways bacteria may acquire the ability to use performed folic acid, bypassing the inhibitory actions of sulfonamides bacteria may alter the target of the abx (e.g. altered forms of the enzymes that make cell walls) |
|
|
Term
|
Definition
- severity ranges from a mild rash to fatal anaphylaxis
- one of the most common drug allergies is allergy to PCN; about 10% of users develops sensitivity to PCNs
- response may develop within 30 min of admin (anaphylaxis, laryngeal edema, shock, dyspnea, skin rxns), within few days, or may occur several days after d/c of tx
- cross-sensitivity-hypersensitivity reaction with any drug in the same chemical class
- all pts must be questioned for previous allergic rxns; allergy prome pts must be observed closely
- important not to label a pt. allergic to a perticular drug w/o adequate documentation
|
|
|
Term
|
Definition
- high serum levels of certain abx and/or prolonged use may cause toxicity by affecting cellular processes in the host directly
- e.g. aminoglycosides can cause ototoxicity by interfering w/ membrane function in the hair cells of the organ of Corti
|
|
|
Term
|
Definition
drug therapy, particularly w/ broad-spectrum antimicrobials or combo of agents can lead to alterations of the normal microbial flora of the upper respiratory, GI, GU tracts, permitting the overgrowth of opportunistic organisms (esp. fungi or resistant bacterial strains) |
|
|
Term
|
Definition
drugs w/ structure containing a beta-lactam ring that is essential for antimicrobial activity include PCNs & cephalosporins bactericidal drugs exhibit some cross-sensitivity (i.e. PCN allergy may translate into a cephalosporin allergy 5-10% of pts) |
|
|
Term
|
Definition
most widely effective & extensively used abx among the least toxic drugs known derived from cultures of molds or manufactured semisynthetically natural PCNs are potent gram-pos. killers; they have little to no coverage against gram-neg. organisms |
|
|
Term
pharmacodynamics of PCNs: |
|
Definition
bactericidal; interfere w/ cell wall synth. by inhibiting biosynthesis of cell wall mucopeptides most effective on rapidly growing organisms have virtually no untoward effec on human cells; safe in children, elderly, and during pregnancy (cat. B) do not cross the BBB except when the meninges are inflamed |
|
|
Term
Subclass of PCNs: natural PCNs/narrow spectrum |
|
Definition
penicillin G (prototype drug, PO/IV/IM) penicillin V (penVeeK) (PO only, less potent) penicillin G procaine (crysticillin A.S.) (IM only, releases PCN over period of 4-24 hrs; used for desensitizing allergic pts) penicillin G benzathine (bicillin L-A) (IM only; long-acting repository form; produces low, but sustained blood levels of PCN for as long as 4 wks) all natural PCNs work the same way but differ in route of admin & stability to gastric acid broad spectrum: gram pos organisms the most (strep, staph)-the most effective; gram neg; gram pos anerobes susceptible to inactivation of B-lactamases (penicillinases) |
|
|
Term
subclass of PCNs: penicillinase-resistant PCNs (antistaphylococcal) |
|
Definition
resistant to penicillinase (bacterial enzyle that hydrolyzes the amide bond of the B-lactam ring) SPECTRUM-use restricted to the tx of infections caused by penicillinase producing staphylococci MRSA-Methicillin Resistant Staphylococcus Aureus - major source of nosocomial or community-acquired infections; usually susceptible only to vancomycin
|
|
|
Term
example of penicillinase resistant PCNs: |
|
Definition
methicillin (staphcillin) IM/IV |
|
|
Term
subclass of PCNs: broad spectrum PCNs (aminopenicillins) |
|
Definition
not resistant to penicillinase SPECTRUM-all of the organisms affected by the natural PCNs, plus are more effective against gram-neg bacilli (salmonella, shigella, etc) resistance to these abx is a major clinical problem b/c of inactivation by plasmoid-mediated penicillinase; frequently resistant: E.coli, H.influenzae (30-40%), M. catarrhalis (70%) important toxicities of ampicillin: incidence of rash is extremely high in pts w/ mono; ampicillin-induced psuedomembraneous colitis is another potential side-effect |
|
|
Term
examples of broad-spectrum PCNs (aminopenicillins) |
|
Definition
amoxicillin (Amoxil) PO ampicillin (Omnipen) PO/IV/IM |
|
|
Term
subclass of PCNs: extended-spectrum PCNs (antipseudomonal) |
|
Definition
SPECTRUM: less effective against the typical Pen G spectrum & ineffective against staphylococci; gram-neg coverage includes: pseudomonas, enterobacter, klebsiella important in treating serious gram-neg bacteria; often used in combo w/ aminoglycosides |
|
|
Term
example of extended-spectrum PCNs |
|
Definition
piperacillin (Pipracil) IV/IM |
|
|
Term
combinations of PCNs w/ B-lactamase inhibitors |
|
Definition
have the same specgrum as the original PCNs + coverage against penicillinase-producing bacgteria such as staph, etc. B-lactamase inhibitors inhibit the enzyme by binding to it & thus protecting the accompanying abx; on their own, B-lactamase inhibitors are not effective in eliminating bacteria |
|
|
Term
examples of combinations of PCNs + B-lactamase inhibitors |
|
Definition
amoxicillin + clavulanic acid = augmentin piperacillin + tazobactam = zosyn |
|
|
Term
contraindications of PCNs |
|
Definition
hypersensitivity & allergy caution with severe renal insufficiency; doses should be adjusted |
|
|
Term
|
Definition
- hypersensitivity rxns: rarely anaphylaxis, urticaria, fever, joint swelling, bronchospasm(#1 toxicity to watch for)
- seizures: may occur in pts w/ poor renal function or in newborns who have immature anion transport systems
- GI disturbances: diarrhea,nausea/emesis, most comme adverse effects
- superinfections
- Pseudomembranous colitis: aminopenicillins & extende-spectrum PCNs-diarrhea caused by a changei nthe flora of the colon or an overgrowth of a toxin-producing strain of clostridium difficile
- electrolyte imbalances: hyperkalemia & hypernatremia possible; b/c PCNs are combined w Na or K, pts may suffer from excess Na/K (i.e. PCNs are salts)
|
|
|
Term
drug/food interactions with PCNs |
|
Definition
- PROBENECID: increased serum levels of PCN by decreasing its renal elimination, thereby increasing serum PCN levels & enhancing PCHs effectiveness (so, need less dose)
- oral contraceptives: decreased effectiveness
- anticoagulants: increased risk of bleeding
- tetracyclines & other bacteriostatic abx: interfere w/ effectiveness of the PCNs
- Antacids: impair the absorption of PO PCNs
- aminoglycosides: chemically inactivated if mixed in a sol'n w/ PCN
- Food: PCN G should be taken on empty stomach w/ full glass of water (but, it's not longer given PO)
- fruit juices (orange) & sodas contribute to decomposition of PCNs & should be avoided w/ PO PCNs
|
|
|
Term
give IM PCN injections _____ |
|
Definition
deep into large muscle mass shake med well before injection & massage the site prior to injection mostly unchanged drug appears in the urine |
|
|
Term
|
Definition
- originate from the Cephalosporium fungi
- chemically related to PCNs: similar mech of activity, renal excretion & allergenicity
- may be used as alternatives when pts are allergic to PCNs: 5-10% cross-over sensitivity
- primarily are bactericidal & act on bacteria by interfering w/ bacterial cell wall synthesis: bacterial cell walls weaken, swell & burst from increased osmotic pressure within the cell causing bacterial cell death
- widely distributed in body fluids; some (not all) enter CNS; mostly eliminated by renal excretion
- resistant to penicillinases but sensitive to other B-lactamases (i.e.cephalosporinases)
|
|
|
Term
cephalosporins are usually well tolerated; side effects are usually minor and include: |
|
Definition
|
|
Term
compared to PCNs, cephalosporins are less active against gram-____ organisms & more active against gram-____ organisms. |
|
Definition
|
|
Term
cephalosporins are organized into four generations based on their order of development & general features of antimicrobial activity from 1st generation to 4th generation, there is: (4) |
|
Definition
decrease in gram-positive coverage increase in gram-negative coverage increase in CNS penetration increase in resistance to B-lactamase |
|
|
Term
first generation cephalosporins |
|
Definition
- preg. category B
- oldest cephalosporins; all have similar spectrum of action
- possess excellent activity against gram-pos bacteria & poor activity against gram-neg organisms
- spectrum: gram-pos cocci, including pneumococci, staphylococci, streptococci (group A is the strep group we worry about)
- enterococci & MRSA not covered
|
|
|
Term
examples of first generation cephalosporins |
|
Definition
cefazolin (Ancef, Kefzol) prototype: IV/IM (most commonly used) cephalexin (Keflex) PO (#1 PO) |
|
|
Term
general clinical use of first generation cephalosporins |
|
Definition
uncomplicated, community-acquired infections of the skin & soft tissue & urinary tract (E.coli) useful for respiratory infections caused by PCN-sensitive streptococcus pneumoniae parenteral 1st generation agents (Ancef) are used for surgical would prophylaxis cefazolin (Ancef) remains the more popular parenteral "1st generation" agent due to its superior blood & tissue conc., low cost, low toxicity |
|
|
Term
second-generation cephalosporins |
|
Definition
- preg. category B
- cover the same organismsas first-generation; less active against gram-pos but w/ increased activity against gram-neg organisms, including H. influenza, M. catarrhalis, S.pneumoniae
|
|
|
Term
example of second-generation cephalosporins |
|
Definition
|
|
Term
general clinical use for second-generation cephalosporins |
|
Definition
community acquired URIs (H.influencae, M. catarrhalis, S. pneumoniae) & uncomplicated UTIs (E.coli) useful in mixed aerobic/anaerobic infections of the skin & soft tissue, intra-abdominal infections, gynecological infections, surgical prophylaxis |
|
|
Term
third-generation cephalosporins |
|
Definition
- preg. category B
- provide extended gram-neg coverage but poor gram-pos coverage (opposite of first generationa agents)
- ceftriaxone is one of two agents of choice for tx of meningitis (adequate CNS penetration)
- no activity against MRSA, enterococci, Listeria
|
|
|
Term
example of third-generation cephalosporines |
|
Definition
ceftriaxone (Rocephin) IV |
|
|
Term
general clinical use of third-generation cephalosporins |
|
Definition
for infections involving gram-neg bacteria, particularly hospital-acquired infections or complicated community-acquired infections of the respiratory tract, blood, intra-abdominal, skin & soft tissue, urinary tract third-generation may be an alternative to aminoglycosides, esp in some pts w/ renal dysfunction b/c of their activity against gram-neg bacteria |
|
|
Term
fourth-generation cephalosporins |
|
Definition
very expensive possess the gram-neg coverage of the third-generation & gram pos coverage of the first-generation cephalosporins |
|
|
Term
example of fourth-generation cephalosporins |
|
Definition
|
|
Term
contraindications of cephalosporins |
|
Definition
- caution in hypersensitivity to PCN; however, b/c this is not always the case, can be administered but w/ caution (5-10% cross-sensitivity)
- caution in pts w/ history of GI or renal disease, especially those receiving diuretics
|
|
|
Term
adverse effects of cephalosporins |
|
Definition
usually tolerated well and are the safest type of abx - hypersensitivity: resembles PCN allergy, most frequent side effect; occurs in 1-2% pts w/o PCN allergy; risk of allergy lower w/ PO route
- disulfiram-like effect: when ingested w/ ETOH or ETOH-containing meds (become violently sick)
- Bleeding: may occur due to vit. K inhibition; admin of vit K corrects the problem
- nephrotoxicity: when used w/ other nephrotoxic drugs & in elderly
- pain at the IM injection site & phlebitis (vein inflammation) at the IV infusion site)
- arthritis
- superinfections
|
|
|
Term
drug interactions with cephalosporins |
|
Definition
- ETOH: antabuse-like effect
- aminoglycosides: increased risk of nephrotoxicity
- aspirin: increased potential risk of bleeding
- anticoagulants: increased anticoagulant effect
- probenecid: decreased excretion of cephalosporins & increased serum levels
|
|
|
Term
other B-lactam antibiotics: Carbapenems |
|
Definition
- broadest spectrum B-lactam antibiotic preparation currently available (safe)
- resists hydrolysis by most B-lactamases
- used frequently in empiric therapy since it is active against penicillinase-producing gram-pos & gram-neg organisms, anaerobes &Pseudomonas aeruginosa
- does not cover MRSA, C.difficile
|
|
|
Term
|
Definition
imipenem/cilastatin (Primaxin) IV/IM |
|
|
Term
adverse effects of carbapenems |
|
Definition
n/v/d seizures in high doses (b/c stays as metabolite in kidney-but cilastatin helps neutralize this problem) --> so, you're safe as long as dose is right |
|
|
Term
other B-lactam antibiotics: Monobactams |
|
Definition
- not as freq. used b/c for specific bacteria
- spectrum: primarily directed against enterobacteria (gram-neg rods in GI); lacks activity against gram-pos organisms & anaerobes
- has low immunogenic potential & shows little cross-sensitivity w/ antibodies induced by other B-lactams, offering a safe alternatve for treating pts allergic to PCNs and/or cephalosporins
|
|
|
Term
|
Definition
aztreonam (Azactam) IV/IM |
|
|
Term
adverse effects of monobactams |
|
Definition
relatively nontoxic/safe; may cause phlebitis, skin rash, and occasionally abnormal liver function tests |
|
|
Term
other agents affecting the cell wall: vancomycin (Vancocin) |
|
Definition
- effective against all gram-pos organisms
- presently reserved for tx of severe infections caused by MRSA or serious gram-pos infection in PCN-allergic pts (b/c not safe)
- also used to treat C.diff-induced pseudomembranous colitis & for prophylaxis in pts w/ prostatic valves who are undergoing oral surgery
- adminstered IV, except when treating pseudomembranous colitis, then PO
- admin IV over 90+ min to avoid Red Man's Syndrome (regardless of dose)
|
|
|
Term
adverse effects of vancomycin |
|
Definition
- fever/chills
- phlebitis at the infusion site
- shock as a result of rapid admin.
- dose related ototoxicity & nephrotoxicity (esp in pts w/ renal failure)
- Red Man's Syndrome: facial flushing & hypotension due to rapid infusion, thought to be caused by histamine release; if occurs, slow admin.
|
|
|
Term
other agents affecting the cell wall: bacitracin |
|
Definition
- used against gram-pos organisms
- use is restricted to topical application b/c of its potential for nephrotoxicity if given systemically
|
|
|
Term
bacterial protein synthesis inhibitors: tetracyclines |
|
Definition
- previously used as bacteriostatic broad-spectrum abx, but not anymore b/c there is so much resistance
- suppress bacterial growth by inhibiting protein synthesis; bind reversibly to the 30S ribosomal subunit, blocking the amino acid-linked RNA from attaching to the ribosome site & inhibiting the protein synth. required for maintaining the bacterial cell
- primarily bacteriostatic but in higher doses may be bacteriocidal
- now used for obscure infections & acne
|
|
|
Term
|
Definition
tetracycline (Sumycin) - generic/cheap but short 1/2 life and must be on empty stomach (1-2 hrs after food) doxycycline (Vibramycin) minocycline (Minocin) - better 1/2 life |
|
|
Term
pharmacotherapeutics of tetracyclines |
|
Definition
- true broad-spectrum abx
- currently rarely used against gram-pos or gram-neg pathogens but used for less common, more atypical infections
- first line drug for Rocky Mountain spotted fever, other rickettsial infections, Lyme disease, many STDs, cholera, malaria, Traveler's diarrhea...
- in PCN-allergic pts used to treat certain STDs, urinary & respiratory tract infections, meningitis
|
|
|
Term
contraindications of tetracyclines |
|
Definition
- pts w/ renal & hepatic dysfunction & bile duct obstruction
- contraindicated in pregnancy & kids before 8 yrs of age; may cause a permanent brown, yellow, or gray discoloration of teeth and may inhibit fetal skeletal growth; may cause severe hepatotoxicity during pregnancy
- contraindicated in hypersensitivity to any tetracycline or sulfite
|
|
|
Term
adverse effects of tetracyclines |
|
Definition
- photosensitivity
- GI: n/v are most common symptoms; these are very irritating to gastric mucosa
- discolorations of both deciduous & permanent teeth
- hepatotoxicity: high dose IV tetracycline that exceeds 2gm/day has been associated w/ liver failure & death
- Phlebitis: tetracyclines are very irritating to veins
- hypersensitivity: anaphylaxis, exfoliative dermatitis, exacerbation of systemic lupus erythematosus, serum sickness seen as fever, rash, arthralgia
|
|
|
Term
drug interactions with tetracyclines |
|
Definition
- oral contraceptives: may decrease in effectiveness
- chelating agents (milk products, calcium, iron, magnesium-containing laxatives, most antacids): impaired absorption due to formation of insoluble ions; should be administered at least 2 hrs before or after any of these agents
- cholestyramine/colestipol: decreased PO absorption of tetracyclines
- concomitant use w/ PCN b/c bacteriostatic drugs (tetracyclines) may interfere w/ the bacterial effect of PCN
- cimetidine: may decrease GI absorption of tetracyclines
- digoxin: may increase levels of digoxin
tetracyclines should be admin. 1 hr before food or 2 hrs after meals w/ a full glass of water |
|
|
Term
bacterial protein synthesis inhibitors: aminoglycosides |
|
Definition
- narrow spectrum bactericidal abx (for serious gram-neg infections)
- limited use due to toxicities; being replaced to some extent by safer abx like third-generation cephalosporins & floroquinolones
- frequently administered w/ PCNs to extend the spectrum (to gram-pos coverage) & take advantage of the synergism btwn these two classes of drugs
|
|
|
Term
|
Definition
|
|
Term
pharmacodynamics of aminoglycosides |
|
Definition
inhibit protein synthesis at the level of the 30S subunit of bacterial ribosome |
|
|
Term
pharmacotherapeutics of aminoglycosides |
|
Definition
must useful in treating infections cased by aerobic gram-neg bacilli and serious nosocomial infections such as gram-neg bacteremia or sepsis; tx of TB often given in combo w/ PCN to encourage facilitation of the aminoglycoside into the cell |
|
|
Term
pharmacokinetics of aminoglycosides |
|
Definition
- PO absorption poor so give parenterally
- do not penetrate CSF
- excreted unchanged by the kidneys
- high conc of these drugs tend to accumulate in the renal cortex & endolymph of the inner ear, which could account for their nephrotoxicity & ototoxicity
- half-life is 1-4 hrs
- have a low TI; require constant monitoring: peak (after 30 min; shows serum toxicity) and trough (30 min before next dose; shows organ toxicity) levels
|
|
|
Term
contraindications with aminoglycosides |
|
Definition
no absolute contradications except in lactation - relative contraindcations are in pts with:
- pre-existing renal disease and/or hearing impairment
- allergy to aminoglycosides
- receiving renal toxic agents (vacomycin)
- receving loop diuretics (Lasix)
- receiving an anesthetic or muscle relaxants
- pregnancy
|
|
|
Term
adverse effects of aminoglycosides |
|
Definition
- ototoxicity
- related to high peak plasma levels& duration of tx
- has been known to affect fetuses in utero
- pts simultaneously receiving another ototoxic drug are at higher risk
- symptoms include: dizziness, tinnitus, vertigo, nystagmus, hearing loss
- nephrotoxicity:
- limited if the drugs are administered for less than 5 days
- at risk: infants, elderly, pts w/ preexisting renal impairment or those receiving concurrent nephrotoxic drugs
- kidney damage may range from mild to severe acute tubular necrosis that can be irreversible
- neuromuscular paralysis: may cause respiratory paralysis; pts w/ myasthenia gravis are particularly at risk as are those receiving anesthetics or muscle relaxants
- allergic reactions: contact dermatitis is a common rxn topically
|
|
|
Term
drug interactions with aminoglycosides |
|
Definition
- additive renal toxic effects are noted if they are given w/ other nephrotoxic agents
- loop diuretics will increased ototoxicity chance
- will increase the effects of neuromuscular blocking agents
- synergistic effect w/ PCNs
- inactivation occurs when they are mixed in the same IV sol'n w/ PCNs
|
|
|
Term
nursing considerations w/ aminoglycosides |
|
Definition
promote adequate fluid intake (2L/day) to maintain adequate renal function admin IV aminoglycosides & PCNs at least 2 hrs apart |
|
|
Term
bacterial protein synthesis inhibitors: macrolides |
|
Definition
- inhibit bacterial protein synthesis by binding to the 50S ribosome
- Bacteriostatic (in higher doses may be bactericidal)
|
|
|
Term
|
Definition
erythromycin (prototype) **comes in different preparations azithromyxin (Zithromax) |
|
|
Term
pharmacotherapeutics of macrolides |
|
Definition
- erythromycin is effective against the same organisms as PCN G; use in pts allergic to PCN; drug of choice for Legionnaire's disease
- Clarithromycin/azithromycin: greater gram-neg coverage; also better penetration into lung tissues & macrophages; drugs of choicein tx of mycoplasma pneumonia
- substitues for PCN to treat respiratory infections caused by streptocuccus pneumoniae
- used for chlamydial infections
|
|
|
Term
contraindications of macrolides |
|
Definition
contraindicated in hypersensitivity & in pts w/ hepatic dysfunction |
|
|
Term
adverse effects of macrolides |
|
Definition
- erythromycin is considered one of the safest abx; hypersensitivity rxns are rare
- GI distress: most common w/ E-mycin (21%) > clarithromycin (10%) > azithromycin (5%)
- superinfections
|
|
|
Term
drug interactions with macrolides |
|
Definition
- erythromycin & clarithromycin are metabolized by the cytochrome P-450 system
- both can reduce the clearance of many other drugs by inhibition of the CYP450 3A4 isoform
- Azithromycin does not undergo metabolism & does not inhibit p-450 (so, don't have to worry about other drugs here)
|
|
|
Term
bacterial protein synthesis inhibitors: lincosamine |
|
Definition
- due to its high potential for serious adverse effects, prescribed only when there is no therapeutic alternative
- inhibits bacterial protein synthesis
- primarily bacteriostatic; bactericidal in high doses
|
|
|
Term
|
Definition
clindamycin (Cleocin) #1topical acne drug; also prophylaxis w/ mitral valve, etc when there's PCN allergy |
|
|
Term
pharmacotherapeutics of licosamine |
|
Definition
usually used to treat severe infections by anaerobic bacteria such as Bacterioides fragilis topical preparations-acne vulgaris, affective against Propionobacterium acnes |
|
|
Term
adverse effects of lincosamine |
|
Definition
- Pseudomembranous colitis: destroys the normal flora which allows Clostridium difficile to grow & secrete its toxin, causing a bloody diarrhea
|
|
|
Term
foliate antagonists: sulfonamides |
|
Definition
- first effective systemic antimicrobials
- deveopment of resistant strains of bacteria & the incidence of allergic reactions to sulfa drugs resulted in their largely being relegated to tx of UTIs, OM & some STDs
- bacteriostatic-act b competitive inhibition of folic a cid synthesis in the microbial cells; decreased folic acid synthesis decreases the number of nucleotides & inhibits bacterial growth
- exhibit wide spectrum of activity against gram-pos & gram-neg bacteria
|
|
|
Term
|
Definition
sulfasalazine (Azulfidine) - frequent use in autoimmune conditions mafenide (Sulfamylon) |
|
|
Term
adverse effects of sulfonamides |
|
Definition
- crystalluria, resulting in renal damage-older agents have low solubility
- adequate hydration & alkalinization of urine prevent the problem by reducing the conc of drug & promoting its ionization
- hypersensitivity
- photosensitivity
- Kernicterus: very high levels of bilirubin in CNS
- sulfa displaces bilirubin from binding sites on serum albumin; bilirubin is free to pass into the CNS
- sulfas should be avoided in newborns & infants less than 3 mo old a s well as pregnant women (can cause permanent brain damage)
|
|
|
Term
foliate antagonists: sulfamethoxazole/trimethroprim |
|
Definition
- combo-greater antimicrobial activity than equivalent quantities of either drug used alone
- UTIs that are caused by E.coli, Enterobacter species, Klebsiella species, etc.
- PCP: primary prophylaxis in clients infected w/ HIV prophylaxis (people having at least one episode of PCP)
- tx of acute exacerbation of chronic bronchitis and otitis media caused by H. influenza or S. pneuomniae
- tx of chancroid, shigelliosis, bacterial prostatitis
|
|
|